Quick Take
Progyny (PGNY) has filed to raise $150 million from the sale of its common stock, per an S-1/A registration statement.
The company provides fertility healthcare services to employees of enterprises and other organizations.
PGNY is growing quickly and is essentially at earnings and operational cash flow breakeven. However, the IPO is highly priced at time of market volatility and negative sentiment.
Company & Technology
New York-based Progyny was founded in 2008 to provide US organizations and their employees with fertility and family building-oriented benefit services.
Management is headed by CEO